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Background: Dysequilibrium syndrome is a genetically heterogeneous condition that combines autosomal
recessive, nonprogressive cerebellar ataxia with mental retardation. The condition has been classified into cerebellar
ataxia, mental retardation and disequilibrium syndrome types 1 (CAMRQ1), 2 (CAMRQ2) and 3 (CAMRQ3) and
attributed to mutations in VLDLR, CA8 and WDR81 genes, respectively. Quadrupedal locomotion in this syndrome
has been reported in association with mutations in all three genes.
Methods: SNP mapping and candidate gene sequencing in one consanguineous Omani family from the United
Arab Emirates with cerebellar hypoplasia, moderate mental retardation, delayed ambulation and truncal ataxia was
used to identify the mutation. In a second unrelated consanguineous Omani family, massively parallel exonic
sequencing was used.
Results: We identified a homozygous missense mutation (c.2117 G> T, p.C706F) in the VLDLR gene in both families
on a shared affected haplotype block.This is the first reported homozygous missense mutation in VLDLR and it
occurs in a highly conserved residue and predicted to be damaging to protein function.
Conclusions: We have delineated the phenotype associated with dysequilibrium syndrome in two Omani families
and identified the first homozygous missense pathogenic mutation in VLDLR gene with likely founder effect in the
southeastern part of the Arabian Peninsula.Background
Dysequilibrium syndrome (DES) is a heterogeneous
autosomal recessive genetic condition characterized by
non-progressive cerebellar ataxia, cerebellar hypoplasia,
moderate-to-profound mental retardation and delayed
ambulation [1]. DES has been reported in American Hut-
terite patients [2-4] as well as in Turkish [5-7], Iranian
[8], Caucasian [9], Iraqi [10] and Saudi [11] patients. DES
belongs to congenital ataxia with cerebellar hypoplasia
group of heterogeneous disorders that are generally char-
acterized by motor disability, muscular hypotonia, lack of
coordination and impaired motor development [12].
Quadrupedal locomotion has been described in a portion
of patients with DES [5,6,10].* Correspondence: l.algazali@uaeu.ac.ae
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reproduction in any medium, provided the orUsing homozygosity mapping, Boycott et al. [4] loca-
lized a gene for DES to chromosome 9 and identified a
199-kb homozygous deletion encompassing the entire
VLDLR gene in affected individuals. Subsequently, a
homozygous nonsense mutation (c.1342C>T, p.R448X)
was identified in an Iranian family [8] and a nonsense
mutation (c.769C >T, p.R257X) and a single nucleotide
deletion (c.2339delT, p.I779fsX3) were identified in
Turkish families [5,6]. More recently, Kolb et al. [13]
have identified a microdeletion encompassing exons 2, 3
and 4 of the VLDLR gene in a Turkish family with
pachygyria and pontocerebellar atrophy. In addition,
mutations in CA8 gene have been implicated in a closely
related syndrome that is characterized by ataxia and
mild mental retardation with predisposition to quadru-
pedal gait [10]. Furthermore, it has been recently shown
that mutations in the WDR81 gene are the underlying
cause of cerebellar hypoplasia and quadrupedal locomo-
tion in a consanguineous Turkish kindred [7].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tein) family, which also includes apolipoprotein E re-
ceptor 2 (ApoER2), the LDL receptor (LDLR), LRP
and Megalin [14]. Members of this family of proteins
are structurally related multifunctional cell-surface
receptors that mediate endocytosis of extracellular
ligands. In addition, these receptors play key roles in a
wide range of physiological processes including the
regulation of lipid metabolism, protection against ath-
erosclerosis, neurodevelopment, signaling and transport
of nutrients and vitamins [14,15]. In particular, VLDLR
is involved in the reelin signalling pathway, which
guides neuroblast migration in the cerebral cortex and
cerebellum [16,17].
In this article, we report the identification of a novel
founder missense mutation in VLDLR gene in two consan-
guineous unrelated Omani families with Dysequilibrium
syndrome, VLDLR type (CAMRQ1, OMIM 224050).Figure 1 Pedigrees of the consanguineous Emirati families of Omani
Double bar represents consanguinity; diamond represents several siblings o
the gray symbol as possibly affected status.Methods
Families were evaluated clinically for signs and symp-
toms related to cognitive impairment and ataxia with
onset in the first year of life. Full general and neuro-
logical assessments and standard brain MRI were per-
formed to document any structural alterations. The
study was approved by the Ethics Committees at both
institutions and informed consents for participation in
the study were obtained from the participants or, where
participants are children, were obtained from a parent.
Peripheral blood samples were collected on all genetic-
ally informative members of both families and DNA was
extracted using Qiagen reagents according to the manu-
facturer’s instructions.
DNA methodologies
For Family 1, a 5 K whole genome linkage SNP scan was
performed using the Illumina Linkage IVb mappingorigins. Both families display typical recessive modes of inheritance.
f varying sex. Affected members are represented by filled symbols and
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Figure 2 Brain MRI of affected individuals from Families 1 and 2. Left: midline parasaggital T1-weighted images showing absent inferior
vermis, and hypoplastic inferior-cerebellum (arrows). Middle: coronal T1-weighted images showing neocortical pachygyria and mega cisterna
magna (*). Right: Axial T2-weighted images showing typical square-shaped midbrain-hindbrain junction morphology in all patients (arrows).
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[19]. The VLDLR candidate gene was sequenced using
primers designed to amplify each of the coding exons
and splice sites using the ExonPrimer software (http://
ihg.gsf.de/ihg/ExonPrimer.html) as described [8]. For
Family 2, exome sequence was generated from individual
IV-8, by exome capture with the Agilent SureSelect
Human All Exome 50 Mb kit, sequenced on an Illumina
HiSeq2000 instrument, resulting in ~95% recovery at
>10x coverage. GATK software [20] was used for variant
identification. These variants were used to identify
identity-by-descent blocks with the online software
HomozygosityMapper [21], set to analysis of blocks con-
taining 200 markers and only flag blocks > 100 markers
in a row. Variants were annotated using SeattleSeq
(http://snp.gs.washington.edu/SeattleSeqAnnotation/) to
identify homozygous potentially deleterious variants. For
SNP genotyping, informative markers from Family 1
were selected based upon the previous 5 K SNP geno-
typing results surrounding the VLDLR gene at 100,000-
1,000,000 bp intervals on chromosome 9 and amplified
in one affected individual from each Family and from ahealthy control individual. PCR amplification was carried
out using a standard touchdown PCR protocol. After
successful amplification, PCR products were sequenced
on an ABI 3730 sequencer (Applied Biosystems, Foster





This family is from UAE of Omani origin and is highly
inbred. There are 4 affected children in two branches
(Figure 1 Family 1). Their ages range from 3 to
14 years. All presented with hypotonia with exagger-
ated reflexes and delayed developmental milestones in
the first year of life. In addition, all had truncal ataxia
and none achieved walking independently. The elder
siblings, however, could walk with help and their gait
was bipedal. Moderate mental retardation was present
in all of them. One of the four affected children had
left side strabismus otherwise ophthalmological exam-









Figure 3 Molecular characterization of Families 1 and 2. A: Linkage plot for Family 1 with major peaks of pLOD score 4 achieved, both for
chr. 9 and chr. 1. x-axis represents chromosomal position, y-axis represents pLOD score. B. Sequence chromatogram from control and affected
individuals from Families 1 and 2, with mutant G to T residue at position chr9:2650382 (c.2117 G> T). C. Conservation of wild-type encoded C
residue across annotated vertebrate species.
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of the children (Table 1). Their weights (10-50%),
heights (5-25%) and head circumferences (10-25%)
were in the normal ranges. Brain MRI demonstrated
diffuse cortical pachygyria without significant white
matter signal abnormality, as well as characteristic
cerebellar hypoplasia but intact pontine volume
(Figure 2). The cerebellar folia were almost completely
absent, and there was vermis greater than hemispheric
hypoplasia. The pons showed a typical square shape
(Figure 2).Family 2
This is also an inbred UAE family of Omani origin (Figure 1
Family 2) and they deny any knowledge of being related to
Family 1. The couple has 9 children with only one affected
child. In addition, the mother’s sister who is 40 years old
now (III-12) has moderate-severe mental retardation and is
unable to walk although we were unable to fully evaluate
her as she lives in Oman. The affected child (IV-8) was the
product of normal pregnancy and delivery. She was noted
to have left side strabismus and was reported to be very
quiet in the first few months of life. Evaluation at three
Table 2 Genotyping from Family 1 and Family 2 surrounding the VLDLR mutation suggests a common ~1,500,000 base
pair haplotype inherited by affected individuals in both families, between base position chr9:2,212,796 and
chr9:3,796,061
RS Number or gene Base Position (chr 9, hg19) Reference Variant Control Family 1 Family 2
rs6474795 1399674 A T T/T T/T T/T
rs1412256 1464067 G C C/C G/G C/C
rs1535842 2212796 C T C/T T/T T/T
rs1331829 2382952 G T G/G G/G G/G
rs729367 2600253 T C T/C T/T T/T
VLDLRc.2117 G> T 2650382 G n/a G/G T/T T/T
rs1455175 3796061 G C C/C C/C C/C
rs4131424 4335668 G A G/A G/A G/G
rs7851353 4411383 A G A/G G/G G/G
rs913258 4877246 C G G/G C/C G/G
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severe hypotonia with exaggerated reflexes. She had
delayed developmental milestones and was unable to
walk unaided at the age of six years. She had no speech
development at all (Table 1). Her weight (10th), height
(>10th) and head circumference (10th) were all normal.
Brain MRI demonstrated cortical pachygyria, cerebellar
hypoplasia, and square-shaped pons, strikingly similar to
the findings in Family 1 (Figure 2).
Identification of a pathogenic missense mutation
In order to identify the genetic cause of disease in Family
1, we performed linkage analysis using a 5 K SNP linkage
panel on each of the members of generation III and IV,
and identified one linkage peak on chromosome 9
(Figure 3A) that overlapped the VLDLR gene locus,
known to cause DES [8]. An additional linkage peak on
chromosome 1 did not contain genes known to cause
neurological disturbances. Direct sequence of each of the
17 exons including canonical splice sites from individual
IV-4 revealed a single probable pathogenic mutation
(Figure 3B) in exon 15 of the VLDLR gene at base pos-
ition chr9:2650382 G>T according to the hg19 build of
the human genome. For Family 2, because we had no
reason to suspect VLDLR gene mutations over the other
DES genes or potentially novel causes, exome sequencing
of the affected child from generation IV (IV-8) was per-
formed and revealed the same chr9:2650382 G>T muta-
tion (Figure 3B). This alteration resulted in a c.2117 G>T
nucleotide change and a p.C706F amino acid substitution
in the transcript NP_003374.3. This change resulted in
altering a cysteine residue that is conserved across all of
vertebrate evolution (Figure 3C). The variant produced a
Grantham score of 205 and a PhastCon score of 1.0
[22,23]. In addition, the mutation was predicted by
PolyPhen-2 [24] to be probably damaging with a score of
1.0, which is the highest score possible. Furthermore, themutation was not identified in dbGaP nor was it encoun-
tered in over 1000 exome sequence analyses from Middle
Eastern patients with other diseases in our in-house
database.
Identification of a common founder haplotype in Family 1
and 2
The finding that the two families shared a common gen-
etic mutation in the VLDLR gene suggested the possibil-
ity of a common founder mutation. In order to test for a
shared affected haplotype, we designed PCR primers at
spaced intervals surrounding the VLDLR mutation,
which were selected to be informative in Family 1 from
the previous 5 K SNP analysis. Amplification from
Family 1 IV-4 and Family 2 IV-8 showed PCR products
of the predicted sizes for all amplicons, and sequence
analysis of each SNP was in full agreement with Family
1 previous SNP analysis. Family 2 genotyping showed
identical homozygous calls for SNPs rs1535842,
rs1331829, rs729367, rs1455175, from base position
2,212,796-3,796,061 on chromosome 9, or a distance of
approximately 1,500,000 base pairs (Table 2). This
haplotype was not encountered in any of ~100 UAE
individuals on whom whole genome SNP results were
reviewed in our lab, suggesting that the mutation oc-
curred on a uniquely shared haplotype and segregated in
the two families.
Discussion
DES is genetically and phenotypically heterogeneous
condition that combines autosomal recessive, non-
progressive cerebellar ataxia and mental retardation with
or without quadrupedal locomotion. This condition has
three types: CAMRQ1 (OMIM 224050), CAMRQ2
(OMIM 610185) and CAMRQ3 (OMIM 613227).
CAMRQ1 has been characterized by cerebellar hypopla-
sia and mental retardation with or without quadrupedal
Figure 4 A model of the predicted structure of R353-K751
residues of the human VLDLR. The model was constructed using
the Swiss Model program (http://swissmodel.expasy.org) with the
full length sequence of the human VLDLR protein. The model has
been visualized using RasMol (http://rasmol.org). According to the
UniProtKP database, cysteine 706 is predicted to form a disulfide
bond with cysteine 719 (Blue colored) (http://www.uniprot.org/
uniprot/P98155).
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VLDLR gene [4-6,8,13]. CAMRQ2 and CAMRQ3 have
been associated with mutations in CA8 and WDR81
genes, respectively [7,10,11]. In this report, we describe
the first homozygous missense mutation (c.2117 G>T;
p.C706F) in VLDLR to cause DES without quadrupedal
locomotion in two unrelated Omani families from UAE.
Genotyping data indicated that the mutation has the
same haplotype in the two families strongly suggesting a
founder effect in the southeastern part of the Arabian
Peninsula.
The mutation is located in the extracellular EGF-like
3 domain of the VLDLR protein. The cysteine residue
at position 706 is highly conserved and is predicted to
be involved in a disulfide bond with cysteine 719
(http://www.uniprot.org/uniprot/P98155; see Figure 4
for the predicted model of the VLDLR domains harbor-
ing the Cys706) and therefore disruption of this residue
is likely to result in misfolding of the protein, its reten-
tion in the endoplasmic reticulum and degradation by
the ER-associated protein degradation machinery
(ERAD) [25,26]. This in turn will lead to loss of the
VLDLR protein function. Degradation by ERAD has
been extensively documented for many of the LDLR
missense mutations [27]. VLDLR and LDLR belong
to the same LRP (LDD-related protein) family pro-
teins [14].
The phenotype (clinical and neuroimaging) in DES,
VLDLR type is highly specific. Affected individuals dem-
onstrate significant truncal ataxia and either learn to
walk late, or never achieve independent ambulation. All
reported individuals with this disorder had intellectual
impairment ranging from moderate to profound. Those
who were able to communicate had dysarthria. The gait
could either be bipedal or quadrupedal. This variability
in the gait has been attributed to the complex inter-
action between environmental factors and the cerebellar
malformation and not the type of causative mutation
[13]. Other variable features reported in this disorder in-
clude strabismus, seizures, short stature and pesplanus.
Brain MRI findings include hypoplasia of inferior por-
tion of the cerebellar vermis and hemispheres, simplified
cerebral gyration with small brain stem and pons [4-
6,8,13]. All affected children in this report had typical
features of this disorder. All had delayed developmental
milestones with moderate mental retardation, truncal
ataxia, and lack of speech while strabismus was present
in some of them. The gait was bipedal in those who
learnt to walk (Table 1). Brain imaging showed typical
abnormalities in all the affected children including cere-
bellar hypoplasia and diffuse cortical pachygyria (Table 1,
Figure 2).
Kaya et al. [11] have recently described the phenotypic
spectrum and molecular analysis of three related familiesfrom northern Saudi Arabia, a neighboring country to
Oman and UAE, with cerebellar ataxia, mental retardation
and DES. Despite some phenotypic variability among the
affected individuals in the three families, they all shared a
homozygous missense mutation (c.484 G>A; p.G162R) in
CA8 gene indicating the possible involvement of modifier
factors. This mutation was different from the one reported
(c.298 T>C; p.S100P) in Iraqi patients [10] excluding the
possibility of a founder effect. The Saudi and Iraqi families
shared mild cognitive impairment, variable degree of cere-
bellar ataxia, absence of seizures and absence of dys-
morphism. However, the patients in the Saudi families did
not exhibit the quadrupedal locomotion that was present
in the Iraqi patients. This is reminiscent to the VLDLR-
associated DES, where some patients with VLDLR
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others did not. It was argued that environmental fac-
tors are the underlying causes of this phenotypic vari-
ation [4,5,8,9,28-30]. The affected individuals in our
two families share a common mutation and founder
haplotype, suggesting that it should be possible to
provide targeted testing for this mutation in patients
from this population.
Conclusions
Our data expand the mutation spectrum of dysequili-
brium syndrome, VLDLR type, and demonstrate the
presence of a missense founder mutation in patients
with this syndrome in the southeastern part of the
Arabian Peninsula.
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